{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:31:05Z","timestamp":1789781465867,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Endometriosis is a debilitating condition that is categorized by the abnormal growth of endometrial tissue outside the uterus. Although the pathogenesis of this disease remains unknown, it is well established that endometriosis patients exhibit immune dysfunction. Interleukin (IL)-33 is a danger signal that is a critical regulator of chronic inflammation. Although plasma and peritoneal fluid levels of IL-33 have been associated with deep infiltrating endometriosis, its contribution to the disease pathophysiology is unknown. We investigated the role of IL-33 in the pathology of endometriosis using patient samples, cell lines and a syngeneic mouse model. We found that endometriotic lesions produce significantly higher levels of IL-33 compared to the endometrium of healthy, fertile controls.\n                    <jats:italic>In vitro<\/jats:italic>\n                    stimulation of endometrial epithelial, endothelial and endometriotic epithelial cells with IL-33 led to the production of pro-inflammatory and angiogenic cytokines. In a syngeneic mouse model of endometriosis, IL-33 injections caused systemic inflammation, which manifested as an increase in plasma pro-inflammatory cytokines compared to control mice. Furthermore, endometriotic lesions from IL-33 treated mice were highly vascularized and exhibited increased proliferation. Collectively, we provide convincing evidence that IL-33 perpetuates inflammation, angiogenesis and lesion proliferation, which are critical events in the lesion survival and progression of endometriosis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-18224-x","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T10:20:09Z","timestamp":1513246809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Interleukin-33 modulates inflammation in endometriosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Jessica E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany P.","family":"Monsanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Khalaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgerally T.","family":"Fazleabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Lessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Koti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakant","family":"Tayade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"18224_CR1","first-page":"151","volume":"64","author":"J Halme","year":"1984","unstructured":"Halme, J., Hammond, M. G., Hulka, J. F., Raj, S. G. & Talbert, L. M. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. \n                           64, 151\u2013154 (1984).","journal-title":"Obstet."},{"key":"18224_CR2","doi-asserted-by":"crossref","unstructured":"Ahn, S. H. et al. Pathophysiology and immune dysfunction in endometriosis. BioMed Research International \n                           2015 (2015).","DOI":"10.1155\/2015\/795976"},{"key":"18224_CR3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12577","author":"JE Miller","year":"2016","unstructured":"Miller, J. E. et al. Implications of immune dysfunction on endometriosis associated infertility. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.12577 (2016).","journal-title":"Oncotarget"},{"key":"18224_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-1-123","volume":"1","author":"CM Kyama","year":"2003","unstructured":"Kyama, C. M., Debrock, S., Mwenda, J. M. & D\u2019Hooghe, T. M. Potential involvement of the immune system in the development of endometriosis. Reprod. Biol. Endocrinol. \n                           1, 123 (2003).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"18224_CR5","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.fertnstert.2015.11.047","volume":"105","author":"SP Monsanto","year":"2016","unstructured":"Monsanto, S. P. et al. Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil. Steril. \n                           105, 968\u2013977.e5 (2016).","journal-title":"Fertil. Steril."},{"key":"18224_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/humrep\/17.3.595","volume":"17","author":"J-Y Kwak","year":"2002","unstructured":"Kwak, J.-Y., Park, S.-W., Kim, K.-H., Na, Y.-J. & Lee, K.-S. Modulation of neutrophil apoptosis by plasma and peritoneal fluid from patients with advanced endometriosis. Hum. Reprod. \n                           17, 595\u2013600 (2002).","journal-title":"Hum. Reprod."},{"key":"18224_CR7","doi-asserted-by":"publisher","first-page":"222ra16","DOI":"10.1126\/scitranslmed.3007988","volume":"6","author":"MT Beste","year":"2014","unstructured":"Beste, M. T. et al. Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci. Transl. Med. \n                           6, 222ra16 (2014).","journal-title":"Sci. Transl. Med."},{"key":"18224_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2916070","volume":"2016","author":"I Jeung","year":"2016","unstructured":"Jeung, I. et al. Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis. Biomed Res. Int. \n                           2016, 1\u20136 (2016).","journal-title":"Biomed Res. Int."},{"key":"18224_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/humrep\/dep071","volume":"24","author":"L Schulke","year":"2009","unstructured":"Schulke, L. et al. Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis. Hum. Reprod. \n                           24, 1695\u20131703 (2009).","journal-title":"Hum. Reprod."},{"key":"18224_CR10","doi-asserted-by":"publisher","first-page":"12451","DOI":"10.1073\/pnas.0703451104","volume":"104","author":"A Hever","year":"2007","unstructured":"Hever, A. et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc. Natl. Acad. Sci. \n                           104, 12451\u201312456 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"18224_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tem.2014.10.003","volume":"26","author":"BD McKinnon","year":"2015","unstructured":"McKinnon, B. D., Bertschi, D., Bersinger, N. A. & Mueller, M. D. Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol. Metab. \n                           26, 1\u201310 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"18224_CR12","doi-asserted-by":"crossref","unstructured":"Yew Liew, F., Girard, J.-P. & Roderick Turnquist, H. Interleukin-33 in health and disease. Nat. Immunol. 16 (2016).","DOI":"10.1038\/nri.2016.95"},{"key":"18224_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00535-014-0982-7","volume":"50","author":"JB Seidelin","year":"2015","unstructured":"Seidelin, J. B. et al. IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis. J. Gastroenterol. \n                           50, 180\u2013190 (2015).","journal-title":"J. Gastroenterol."},{"key":"18224_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3899\/jrheum.170020","volume":"44","author":"JH Han","year":"2017","unstructured":"Han, J. H. et al. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still\u2019s Disease. J. Rheumatol. \n                           44, 740\u2013747 (2017).","journal-title":"J. Rheumatol."},{"key":"18224_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni1050","volume":"5","author":"EK Brint","year":"2004","unstructured":"Brint, E. K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. \n                           5, 373\u2013379 (2004).","journal-title":"Nat. Immunol."},{"key":"18224_CR16","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","volume":"3","author":"C Moussion","year":"2008","unstructured":"Moussion, C., Ortega, N. & Girard, J.-P. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel \u2018Alarmin\u2019? PLoS One \n                           3, e3331 (2008).","journal-title":"PLoS One"},{"key":"18224_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew, F. Y., Girard, J.-P. & Turnquist, H. R. Interleukin-33 in health and disease. Nat. Rev. Immunol. \n                           16, 676\u2013689 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"18224_CR18","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1074\/jbc.M111.298703","volume":"287","author":"R Kakkar","year":"2012","unstructured":"Kakkar, R., Hei, H., Dobner, S. & Lee, R. T. Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells. J. Biol. Chem. \n                           287, 6941\u20136948 (2012).","journal-title":"J. Biol. Chem."},{"key":"18224_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer, B. & Paczesny, S. The ST2\/IL-33 Axis in Immune Cells during Inflammatory Diseases. Front. Immunol. \n                           8, 475 (2017).","journal-title":"Front. Immunol."},{"key":"18224_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/sji.12312","volume":"82","author":"A Ahmed","year":"2015","unstructured":"Ahmed, A. & Koma, M. K. Interleukin-33 Triggers B1 Cell Expansion and Its Release of Monocyte\/Macrophage Chemoattractants and Growth Factors. Scand. J. Immunol. \n                           82, 118\u2013124 (2015).","journal-title":"Scand. J. Immunol."},{"key":"18224_CR21","first-page":"3","volume":"12","author":"Y-J Chang","year":"2011","unstructured":"Chang, Y.-J. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. \n                           12, 3\u20131 (2011).","journal-title":"Nat. Immunol."},{"key":"18224_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jri.2015.01.004","volume":"109","author":"W-T Hu","year":"2015","unstructured":"Hu, W.-T. et al. Decidual stromal cell-derived IL-33 contributes to Th2 bias and inhibits decidual NK cell cytotoxicity through NF-\u03baB signaling in human early pregnancy. J. Reprod. Immunol. \n                           109, 52\u201365 (2015).","journal-title":"J. Reprod. Immunol."},{"key":"18224_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz, J. et al. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity \n                           23, 479\u2013490 (2005).","journal-title":"Immunity"},{"key":"18224_CR24","doi-asserted-by":"publisher","first-page":"e52252","DOI":"10.1371\/journal.pone.0052252","volume":"7","author":"MS Salker","year":"2012","unstructured":"Salker, M. S. et al. Disordered IL-33\/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One \n                           7, e52252 (2012).","journal-title":"PLoS One"},{"key":"18224_CR25","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/humrep\/des154","volume":"27","author":"P Santulli","year":"2012","unstructured":"Santulli, P. et al. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum. Reprod. \n                           27, 2001\u20132009 (2012).","journal-title":"Hum. Reprod."},{"key":"18224_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2015.05.002","volume":"166","author":"M Mbarik","year":"2015","unstructured":"Mbarik, M., Kaabachi, W., Henidi, B., Sassi, F. H. & Hamzaoui, K. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population. Immunol. Lett. \n                           166, 1\u20135 (2015).","journal-title":"Immunol. Lett."},{"key":"18224_CR27","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1073\/pnas.0712116105","volume":"105","author":"WA Verri","year":"2008","unstructured":"Verri, W. A. et al. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl. Acad. Sci. \n                           105, 2723\u20132728 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"18224_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2016.08.007","author":"NL Millar","year":"2016","unstructured":"Millar, N. L., O\u2019Donnell, C., McInnes, I. B. & Brint, E. Wounds that heal and wounds that don\u2019t \u2212 The role of the IL-33\/ST2 pathway in tissue repair and tumorigenesis. Semin. Cell Dev. Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2016.08.007 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"issue":"Suppl 2","key":"18224_CR29","doi-asserted-by":"publisher","first-page":"i101","DOI":"10.1136\/annrheumdis-2011-200589","volume":"71","author":"FY Liew","year":"2012","unstructured":"Liew, F. Y. IL-33: a Janus cytokine. Ann. Rheum. Dis. \n                           71(Suppl 2), i101\u20134 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"18224_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1189\/jlb.3RU0115-012R","volume":"98","author":"Q Gao","year":"2015","unstructured":"Gao, Q., Li, Y. & Li, M. The potential role of IL-33\/ST2 signaling in fibrotic diseases. J. Leukoc. Biol. \n                           98, 15\u201322 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"18224_CR31","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","volume":"114","author":"Y-S Choi","year":"2009","unstructured":"Choi, Y.-S. et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production. Blood \n                           114, 3117\u20133126 (2009).","journal-title":"Blood"},{"key":"18224_CR32","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1172\/JCI63802","volume":"123","author":"MY Tjota","year":"2013","unstructured":"Tjota, M. Y. et al. IL-33-dependent induction of allergic lung inflammation by Fc\u03b3RIII signaling. J. Clin. Invest. \n                           123, 2287\u201397 (2013).","journal-title":"J. Clin. Invest."},{"key":"18224_CR33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jaci.2013.05.012","volume":"132","author":"JL Barlow","year":"2013","unstructured":"Barlow, J. L. et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. \n                           132, 933\u201341 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"18224_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imm.12111","volume":"140","author":"PN Pushparaj","year":"2013","unstructured":"Pushparaj, P. N. et al. Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology \n                           140, 70\u20137 (2013).","journal-title":"Immunology"},{"key":"18224_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/imm.12589","volume":"148","author":"S Shan","year":"2016","unstructured":"Shan, S. et al. Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate. Immunology \n                           148, 83\u201391 (2016).","journal-title":"Immunology"},{"key":"18224_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1177\/1933719115592713","volume":"22","author":"C Tosti","year":"2015","unstructured":"Tosti, C., Pinzauti, S., Santulli, P., Chapron, C. & Petraglia, F. Pathogenetic Mechanisms of Deep Infiltrating Endometriosis. Reprod. Sci. \n                           22, 1053\u20131059 (2015).","journal-title":"Reprod. Sci."},{"key":"18224_CR37","doi-asserted-by":"crossref","unstructured":"Kurowska-Stolarska, M. et al. IL-33 Induces Antigen-Specific IL-5\u2009+\u2009T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4. J. Immunol. 181 (2008).","DOI":"10.4049\/jimmunol.181.7.4780"},{"key":"18224_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijgo.2016.01.018","volume":"134","author":"A Mosbah","year":"2016","unstructured":"Mosbah, A., Nabiel, Y. & Khashaba, E. Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis. Int. J. Gynecol. Obstet. \n                           134, 247\u2013251 (2016).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"18224_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/JID.2015.406","volume":"136","author":"GD Rak","year":"2016","unstructured":"Rak, G. D. et al. IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing. J. Invest. Dermatol. \n                           136, 487\u201396 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"18224_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.07.005","author":"SH Ahn","year":"2016","unstructured":"Ahn, S. H. et al. Immune-inflammation gene signatures in endometriosis patients. Fertil. Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.07.005 (2016).","journal-title":"Fertil. Steril."},{"key":"18224_CR41","unstructured":"Draijer, C. et al. Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33. Eur. Respir. J. 40 (2014)."},{"key":"18224_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. \n                           55, 611\u201322 (2009).","journal-title":"Clin. Chem."},{"key":"18224_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ygyno.2017.03.007","volume":"145","author":"K K. Au","year":"2017","unstructured":"K. Au, K. et al. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer. Gynecol. Oncol. \n                           145, 436\u2013445 (2017).","journal-title":"Gynecol. Oncol."},{"key":"18224_CR44","unstructured":"Gilles Carpentier. Angiogenesis Analyzer for ImageJ. (2012). Available at: http:\/\/image.bio.methods.free.fr\/ImageJ\/?Angiogenesis-Analyzer-for-ImageJ (Accessed: 4th July 2017)."},{"key":"18224_CR45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12539","author":"K Khalaj","year":"2016","unstructured":"Khalaj, K. et al. RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.12539 (2016).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18224-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:59:34Z","timestamp":1671796774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["18224"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18224-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17903"}}